Applications published 27 December 2006

Pharmaceutical compsn for treating hair loss and benign prostatic hyperplasia
Lee, Eun-Joo 1734918*

Method for the cosmetic tratiment of wrinkled skin using a cosmetic compsn containing a tightening agent and a dispersion of solid particles of a grafted acrylic polymer
L'Oreal 1734919*

Combination of a NMDA receptor antagonist and an MAO-inhibitor or a GADPH-inhibitor for the treatment of psychiatric conditions
Neuromolecular 1734920*

Coated tablet formulation and method
Bristol-Myers Squibb 1734921*

Antimicrobial compsns
ISP Investments 1734922*

Zinc preservative compsn and method of use
Bausch & Lomb 1734923*

Deferasirox dispersible tablets
Novartis 1734924*

Novel compsns for topical delivery
Panacea Biotec 1734925*

Aqueous solutions comprising predinisolone and a cyclodextrin derivative
Allergan 1734926*

Pimecrolimus foam compsn containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbine and/or medium chain tryglycerides
Novartis 1734927*

Serum-stable amphoteric liposomes
novosom 1734928*

Microparticles for cell delivery
Ethicon 1734929*

Low dose pharmaceutical products
SmithKline Beecham 1734930*

Formulations of ramipril
Actavis Group 1734931*

Pharmaceutical compsns comprising an amphoteric starch
Vectura 1734932*

Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (LK-423)
LEK Pharmaceuticals 1734933*

Dosage form having polymeric stability
Dr Reddy's Laboratories Ltd; Dr Reddy's Laboratories Inc 1734934*

Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
Amylin Pharmaceuticals; Alkermes Controlled Therapeutics 1734935*

Amphiphilic star-like, or scorpion-like macromolecules, various compsns and uses thereof
Rutgers, The State University 1734936*

Nanoparticle formulations of platinum compounds
Cell Therapeutics Europe 1734937*

Insulin highly respirable microparticles
Universita' Degli Studi di Parma 1734938*

Antiparasitic compounds and methods of their use
The Regents of the University of California Office of Technology Transfer 1734939*

Combination of deramiciclane and opioids as analgesics
EGIS Gyogszergyar 1734940*

Neural tourniquet
The Feinstein Institute for Medical Research 1734941*

Substituted urea and carbamate, phenacyl-2-hydroxy-3-diamino-alkane, and benzamide-protease inhibitors
Elan Pharmaceuticals 1734942*

Use of capsaicin and capsaicinoids for diagnosing chemical hypertensibility
Hammer, Johann 1734943*

4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventative and therapeutic agent for cancer
Istituto Nazionale per lo Studio e la Cura dei Tumori 1734944*

A compsn containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity
The University of Sydney 1734945*

Method of using punicic acid to enhance immune response and prevent metabolic disorders
Nutrition Therapeutics 1734946*

Expression of fatty acid desaturases in corn
Monsanto Technology 1734947*

Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
Wayne State University 1734948*

Purifications of ellagitannins
The Regents of the University of California 1734949*

Treating a viral disorder
Elixir Pharmaceuticals 1734950*

Diphenyl-indol-2-on compounds and their use in the treatment of cancer
TopoTarget 1734951*

Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection
Novartis 1734952*

Co-formulations of kits of bioactive agents
Abeille Pharmaceuticals 1734953*

Efficacious compsn of a benzimidazole, an avermectin and praziquantel and related methods of use
Intervet International 1734954*

Compsns of an anticonvulsant and an antipsychotic drug for affecting weight loss
Duke University 1734955*

Treatment of impaired respiratory function with gaboxadol
H Lundbeck 1734956*

Thiazole sulphonamide compounds for the treatment of neurodegenerative disorders
Pfizer Products 1734957*

Methods for the treatment of hypertension
Merck 1734958*

Method of treating schizophrenia and/or glucoregulatory abnormalities
Aventis Pharmaceuticals 1734959*

Methods for the treatment of hypertension
Merck 1734960*

Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
Elan Pharmaceuticals 1734961*

Compsns and methods for modulating gated ion channels
PainCeptor Pharma 1734962*

Method of treating men with metabolic and anthropometric disorders
Merck 1734963*

17-beta-acetamide-4-azasteroids and androgen receptor modulators
Merck 1734964*

New compsns and methods for maintaining eyelid hygiene
Advanced Vision Research 1734965*

Piperizinylpiperidine derivatives as chemokine receptor antagonists
Incyte Corp 1734966*

Pyrrolo [2,3-D] pyrimidine compounds for treating transplant rejection
Pfizer Products 1734967*

Use of 9H-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9H-purine-2,6-diamine derivatives
Novartis 1734968*

Novel anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RYR2) and uses thereof
The Trustees of the Columbia University in the City of New York 1734969*

Treatment of fibrosis using FXR ligands
Intercept Pharmaceuticals 1734970*

Polymer-based sustained release device
Alkermes Controlled Therapeutics 1734971*

Method of treating solid tumours and leukaemias using combination therapy of vitamin D and anti-metabolic nucleoside analogues
Roswell Park Cancer Institute 1734972*

Novel method of neuroprotection by pharmacological inhibition of AMP-activated protein kinase
Fasgen; The Johns Hopkins University 1734973*

D-ribose for improving depression-like symptoms
Tanabe Seiyaku 1734974*

Herbal therapy for the treatment of food allergy
Li, Xiu-Min 1734975*

Extracts of Scutellaria for the treatment of SARS
Phynova 1734976*

Medicament for the treatment of joint disorders and inflammatory conditions
Helgason, Larus 1734977*

Tissue detoxification and health supplements and methods of making and using them
Takemodo, Arnold 1734978*

Follicle stimulating hormone superagonists
Trophogen 1734979*

Use of peptidic compounds for the prophylaxis and treatment of chronic headache
Schwarz Pharma 1734980*

Treatment of neurological conditions using complement C5A receptor modulators
Promics Pty 1734981*

Cell penetrating SOCS polypeptides that inhibit cytokine-induced signalling
Vanderbilt University 1734982*

Modified annexin proteins and methods for treating thrombosis
Alavita Pharmaceuticals 1734983*

Compsns and methods for topical diagnostic and therapeutic transport
ReVance Therapeutics 1734984*

Methods for suppressing neovascularisation using ephrinB2
Aqumen Biopharmaceuticals 1734985*

Method of modulating appetite
St Vincent's Hospital Sydney 1734986*

Interferon-beta for antivirus therapy for respiratory diseases
University of Southampton 1734987*

Interferon-beta polymer conjugates
Enzon Pharmaceuticals 1734988*

Novel use of antisecretory factor
As-Faktor 1734989*

Use of corticotroph-derived glycoprotein hormone to treat liver steatosis
ZymoGenetics 1734990*

Compsns with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
Avirid 1734991*